Valuation
Is the price right?2/2 inputs reported · High confidence
Stronger than most peers on:
- ▲ P/B
- ▲ Earnings yield
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Oct 1, 2026
2/2 inputs reported · High confidence
Stronger than most peers on:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Stronger than most peers on:
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Held back by:
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Net income (12 months) | 320.7M USD | 356.0M USD | +11.0% |
| Debt | 1.4B USD | 1.7B USD | +25.0% |
| Cash | 960.4M USD | 871.8M USD | −9.2% |
| Shares outstanding | 96.2M | 95.9M | −0.3% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Banks - Regional are within their usual range since 2016.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Return on assets (ROA) | 1.4% | 1.1% | 0.9% | 0.8% | 0.8% | ▼ 0.0 pts |
| Return on equity (ROE) | 9.0% | 7.9% | 6.3% | 5.4% | 5.5% | ▲ 0.1 pts |
| Debt to equity | 0.17× | 0.46× | 0.68× | 0.53× | 0.40× | ▼ 24% |
Price history is added with the daily price update and will appear after the next one.